Patient Preferences for topical Psoriasis treatments

Patient Preferences for topical Psoriasis treatments - PsoPref

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027846

Enrollment

220

Registered

2022-01-20

Start date

2015-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L40.0

Interventions

Group 1: Conjoint Analyses

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: physician-confirmed diagnosis of plaque-type psoriasis written informed consent, sufficient language skills and the ability to understand the study task

Exclusion criteria

Exclusion criteria: age < 18 years

Design outcomes

Primary

Measure	Time frame
The aim of the present study is to use a computer-based conjoint analysis to record the preferences of psoriasis patients with regard to topical therapy. The preferences are measured using the relative importance of the attributes (Relative Importance Scores= RIS) at the end of the survey for each participant .	—

Secondary

Measure	Time frame
Characteristics that influence RIS	—

Countries

Germany

Contacts

Public ContactMarthe Schaarschmidt

Klinik für Dermatologie

marthe-lisa.schaarschmidt@umm.de+496213832280

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026